OVERVIEW



BHT-DNA TECHNOLOGY

Technology Overview

Additional Technologies



PRODUCT PIPELINE

Pipeline Summary

BHT-3009 for Multiple Sclerosis

BHT-3021 for Type 1 Diabetes

BHT-3034 Mysethenia Gravis

CLINICAL TRIALS

this area is currently being updated



INVESTOR RELATIONS

Press Releases

Management

Our Founders

Board of Directors

Scientific Advisory Board

Clinical Advisory Board

Investors

NEWS & PUBLICATIONS

Press Releases

Publications

Abstracts



CONTACT US

Contact Info

Careers

Directions